Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies

Supportive Care in Cancer

Volumn 25, Issue 7, 2017, Pages 2313-2319

  Lebrun, F ^a   Klastersky, J ^a   Levacq, D ^a   Wissam, Y ^a   Paesmans, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Cancer patients; Erythropoiesis stimulating agents; Iron deficiency anemia; Iron therapy

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; IRON;

ANAPHYLAXIS; BLOOD TRANSFUSION; CANCER PATIENT; DRUG HYPERSENSITIVITY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOPHOSPHATEMIA; IRON DEFICIENCY ANEMIA; IRON THERAPY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ANEMIA; ANEMIA, IRON-DEFICIENCY; COMPLICATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEOPLASMS; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; ANEMIA; ANEMIA, IRON-DEFICIENCY; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE;

EID: 85017111586     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-017-3672-1     Document Type: Review

References (34)

1. Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372:1832–1843
2. Macciò A, Madeddu C, Gramignano G et al (2015) The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 100:124–132
3. Steegman JL, Sánchez Torres JM, Colomer R et al (2013) Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey. Clin Transl Oncol 15:477–483
4. Link H, Schmitz S (2013) Treatment of cancer-associated anaemia: results from a two-day cross-sectional survey in Germany. Onkologie 36:266–272
5. Schrijvers D, De Samblanx H, Roila F, on behalf of the ESMO Guidelines Working Group (2010) Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO clinical practice guidelines for use. Ann Oncol 21:v244–v247
6. de Castro J, Gascón P, Casa A, Muñoz-Langa J et al (2014) Iron deficiency in patients with solid tumours: prevalence and management in clinical practice. Clin Transl Oncol 9:823–828
7. Aapro M, Österborg A, Gascón P et al (2012) Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol 23:1954–1962
8. Steinmetz T, Tschechne B, Harlin O et al (2013) Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Ann Oncol 24:475–482
9. Petrelli F, Borgonovo K, Cabiddu M et al (2012) Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. J Cancer Res Clin Oncol 138:179–187
10. Gafter-Gvili A, Rozen-Zvi B, Vidal L et al (2013) Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia—systematic review and meta-analysis of randomized controlled trials. Acta Oncol 52:18–29
11. Kobune M, Miyanishi K, Takada K et al (2011) Establishment of a simple test for iron absorption from the gastrointestinal tract. Int J Hematol 93:715–719
12. Durigova A, Lamy PJ, Thezenas S et al (2013) Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification. Clin Chem Lab Med 51:1833–1841
13. Steinmetz HT. The role of intravenous iron in the treatment of anemia in cancer patients. Ther Adv Hematol 2012; 0:1–15
14. Dangsuwan P, Manchana T (2010) Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. Gynecol Oncol 116:522–525
15. Kim YT, Kim SW, Yoon BS et al (2007) Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol Oncol 105:199–204
16. Abdel-Razeq H, Abbasi S, Saadi I et al (2013) Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. Drug Design, Development and Therapy 7:939–944
17. Keeler BD, Simpson JA, Ng S et al (2014) The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. Color Dis 16:794–800
18. Hedenus M, Karlsson T, Ludwig H et al (2014) Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy. Med Oncol 31:302
19. Calleja JL, Delgado S, del Val A et al (2016) Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. Int J Color Dis 31:543–551
20. Toledano A, Luporsi E, Morere JF et al (2016) Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France. Support Care Cancer 24:67–75
21. Yoon HM, Kim YW, Ham BH et al (2014) Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer. World J Gastroenterol 20:1852–1857
22. Titos-Arcos JC, Soria-Aledo V, Carrillo-Alcaraz A et al (2012) Is intravenous iron useful for reducing transfusions in surgically treated colorectal cancer patients? World J Surg 36:1893–1897
23. Ferrari P, Nicolini A, Manca ML et al (2012) Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate. Biomed Pharmacother 66:414–418
24. Keating GM (2014) Ferric carboxymaltose: a review of its use in iron deficiency. Drugs. doi:10.1007/s40265-014-0332-3
25. Ibrahim AS, Spellberg B, Walsh TJ et al (2012) Pathogenesis of mucormycosis. CID 54:S16–S22
26. Nairz M, Schroll A, Demetz E et al (2015) ‘Ride on the ferrous wheel’—the cycle of iron in macrophages in health and disease. Immunobiology 220:280–294
27. Dadwal SS, Tegtmeier B, Liu X et al (2014) Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation. Eur J Heamatol 94:235–242
28. Patil PS, Mohandas KM, Bhatia SJ et al (2014) Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study. Indian J Gastroenterol 33:12–18
29. Gilreath JA, Stenehjem DD, Rodgers GM (2012) Total dose iron dextran infusion in cancer patients: is it safe? JNCCN 10:669–676
30. De Castro J, Gascòn P, Casas A et al (2014) Iron deficiency in patients with solid tumours: prevalence and management in clinical practice. Clin Transl Oncol 16:823–828
31. Cella D, Kallich J, McDermott A et al (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15:979–986
32. Laï-Tiong F, Brami C, Dubroeucq O et al (2016) Management of anemia and iron deficiency in a cancer center in France. Support Care Cancer 24:1091–1096
33. Fraenkel PG. Understanding anemia of chronic disease. American Society of Hematology
34. Van Santen S, de Mast Q, Oosting ID et al (2014) Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica 99:e171–e173